Clinical Trials Logo

Filter by:
NCT ID: NCT05746156 Completed - Clinical trials for Locally Advanced Cervical Cancer

Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study

LaMA
Start date: July 20, 2020
Phase: N/A
Study type: Interventional

Lymphatic mapping is a procedure in which all lymph nodes with drainage from the primary tumor, i.e. all nodes with potential (micro)metastases, can be imaged. These nodes are not necessarily suspicious on other imaging techniques. The goal of this feasibility study is to 1. investigate the feasibility of the lymphatic mapping procedure in locally advanced cervical cancer 2. study the agreement of the lymphatic map with the radiotherapy treatment plan including previous imaging (MRI / CT / FDG-PET/CT)

NCT ID: NCT05738291 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood

Start date: April 26, 2023
Phase: Phase 1
Study type: Interventional

Effects of multiple rising doses of BI 1839100 on safety, tolerability, pharmacokinetics and the effect of high-fat meal on pharmacokinetics of BI 1839100 will be assessed as well as assessing potential drug-drug interactions.

NCT ID: NCT05732350 Completed - Solid Tumor Clinical Trials

Exploratory Drug Interaction Study Between SMIs and DOACs

Start date: November 11, 2021
Phase:
Study type: Observational

The main objective of this study is to investigate the effect of small molecule inhibitors (SMIs), used in targeted therapy for tumours, on direct oral anticoagulants (DOACs).

NCT ID: NCT05731999 Completed - Drug Abuse Clinical Trials

A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

This is a pre-market, explorative, early feasibility, pilot, controlled clinical investigation designed to collect initial clinical data on the medical device Previct Drugs.

NCT ID: NCT05730634 Completed - Clinical trials for Diabetes Mellitus, Type 2

The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT

CARAMEL
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

To study the effect of atorvastatin treatment on vascular uptake of 68Ga-DOTATATE in patients with Type 2 Diabetes.

NCT ID: NCT05723406 Completed - Osteoarthritis, Hip Clinical Trials

The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study

MAGIC
Start date: March 21, 2023
Phase: Phase 2
Study type: Interventional

Monocenter randomized controlled proof of principle study to investigate the effect of sugammadex at the end of total hip replacement surgery on the postoperative innate immune function

NCT ID: NCT05721989 Completed - Clinical trials for Healthy Participants

A Research Study Looking Into Blood Levels of Three Different Formulations of the Study Medicine Ziltivekimab

Start date: February 3, 2023
Phase: Phase 1
Study type: Interventional

A research study to investigate how quickly and to what extent different compositions of the study medicine ziltivekimab are absorbed, transported, and eliminated from the body. Ziltivekimab is not yet approved for market. The study medicine will be injected under the skin (this is called subcutaneous administration). Two different administration methods will be compared: a syringe and a pen-injector. A pen-injector is a device that is developed to make injections more easy and convenient. They are for example used by diabetes patients to inject insulin. It will also be investigated how safe ziltivekimab is and how well it is tolerated when it is used by healthy participants. Ziltivekimab has already been administered to patients with chronic kidney disease or rheumatoid arthritis. The current study will be the first study where ziltivekimab will be given to healthy participants.

NCT ID: NCT05718687 Completed - Sickle Cell Disease Clinical Trials

A GBT021601 ADME Microtracer Study in Healthy Volunteers

Start date: December 22, 2022
Phase: Phase 1
Study type: Interventional

An Open-label Study of GBT021601 in 8 to 10 healthy male or female participants to evaluate the absorption, distribution, metabolism, and excretion (ADME) of GBT021601.

NCT ID: NCT05714189 Completed - Endometriosis Clinical Trials

The Effect of Dietary Interventions, or no Intervention, on Pain and Quality of Life in Women Diagnosed With Endometriosis

Dieetstudie
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This prospective pilot study was performed to explore the influence of a dietary intervention, the Low FODMAP diet or endometriosis diet, on endometriosis-related pain and Quality of Life (QoL). Participants could choose between adherence to a diet; the Low FODMAP diet or endometriosis diet, or to contribute to the control group and not adhere to a diet.

NCT ID: NCT05713188 Completed - Haemofiltration Clinical Trials

Clinical Investigation of the Safety of the MediSieve Magnetic Haemofiltration System in Healthy Volunteers

Start date: June 13, 2022
Phase: Phase 1
Study type: Interventional

This is a single-centre, non-randomised, prospective study to assess the safety of the MediSieve blood filtration system in healthy volunteers